SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (19544)8/14/2004 4:40:08 PM
From: Paul Senior  Read Replies (1) of 78603
 
OT: ABC (and CAH and MCK) very disappointing. I continue to hope that they have viable drug distribution businesses. I am skeptical, but I continue to hold.

--------
Sam Isaly, portfolio manager of Eatan Vance Health Sciences Fund was again on Louis Rukeyser's show last night. Isaly's pretty sharp, imo. He and his team have had some great successes in their pharma and biotech stock picks. Among the stocks he holds and recommends are a couple mentioned here - AMGN, NVS. He also likes LLY. Maybe it's time for me to up my few exploratory AMGN shares and re-look at Lilly. Anyone here with an opinion on any of these now?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext